Injectable Cosmetic Procedures for the Male Patient

September 2015 | Volume 14 | Issue 9 | Original Article | 1043 | Copyright © September 2015


Isabela T. Wieczorek MD,a Brian P. Hibler BS,b and Anthony M. Rossi MDc

aDepartment of Dermatology, Weill Cornell Medical College, New York, NY
bDepartment of Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY
cDermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY;
Weill Cornell Medical College, New York, NY; New York Presbyterian Hospital, New York, NY

membrane of adipocytes, leading to mild inflammation and phagocytosis by macrophages. 47
More recently, a synthetically derived, purified formation of deoxycholic acid, or ATX-101, has undergone phase III trials for treatment of submental fat. McDiarmid et al. examined the pooled data of two European randomized phase 3 trials of ATX-101, which included 716 patients with a moderate or severe submental convexity and prominent to marked localized submental fat.48
ATX-101 (1 or 2 mg/cm2) was given in up to four treatment sessions separated by approximately 28 days.48 At each session, patients received up to 0.2 ml at 1 cm intervals to the preplastysmal submental fat. Patients received a maximum of 50 injections and 10mL per session. Patients were then followed 4 and 12 weeks after the completion of treatment. ATX-101 was effective based on clinician-rated efficacy outcomes, a subjective self-rating scale, and caliper measurements. Adverse events included pain, edema, bruising, bleeding, numbness, erythema, and induration. These adverse events resulted in discontinuation in 7 and 10% of patients treated with ATX-101 1 and 2 mg/cm2, respectively. Five cases of injection-site nerve injury occurred with the higher ATX-101 dose; none of the cases resulted in permanent symptoms.48
Males comprised 26% of treated patients. It is important to note that male patients only achieved statistical significance compared to placebo with the 2 mg/cm2 concentration of ATX-101. Additionally, the authors found that although male patients age 18-30 experienced improvement, it was not statistically significant when compared to placebo. There may not have been enough power to show significance in this subgroup.48

Lips

With age, men experience thinning of the lip, blunting of the vermillion border and philthral columns, and downward projection of the angle of mouth. Perioral lines tend to be less severe than in women, thought to be secondary to smaller pilosebaceous units.49
The goals of lip restoration must be fully discussed with the patient. Under-correction is the safest approach to avoid a feminine lip. Overall, the volume ratio of the upper to lower lip should be one-third to two-thirds, and the upper lip should protrude 1 to 2 mm anteriorly compared to the lower lip. Ethnicity and cultural differences must be kept in mind, as patients of African descent tend to have fuller lips.50
Less viscous HA products are preferable, like Restylane® , Juvéderm® Ultra and Ultra XC, and Restylane® Silk. The patient should be warned about post-procedural edema, as HA fillers absorb water and can increase in size by 10-15%.1 Non-hyaluronic acid fillers have an increased rate of nodules and granulomas in the lips, and thus their use is not recommended.

Nose

With age, the male nasal tip drops, causing an elongated nose that worsens with smiling. As rhinoplasty is the third most common procedure in men, neurotoxin and soft tissue filler can be used in an off-label manner to re-shape or restore nasal structures. In males, the desirable nasolabial angle tends to be smaller than in females (97 degrees versus 104.9).51 Therefore, a nasal tip that is too elevated can feminize the male face. Additionally, the male radix starts at about the superior tarsal fold, which is higher than in females.52 Another area that should be considered is the dorsum of the nose. In men, the dorsum of the nose approaches a straight line drawn from the radix to the nasal tip; females tend to have a more sloping line. Accordingly, nasal root and dorsum augmentation has become a popular procedure for the Asian patient, who tends to have a flatter radix and dorsum.53 The ethnic background of the patient of the patient must be taken into account as nasal proportions vary greatly with ethnicity.
A hypertrophied depressor septi nasi can lead to nasal tip ptosis and upper lip shortening. The muscle arises from the orbicularis oris and periosteum above the central and lateral incisors, then inserts onto the nasal septum and/or medial cura.54 Injecting neurotoxin into this muscle can elevate the nasal tip. Small aliquots should be placed to avoid diffusion into the orbicularis oris, which is only 3 cm away. Another muscle that contributes to the nasal tip is the musculus digastricus septi nasi labialis. This muscle pulls the nasal tip downward while lifting the upper lip. Neurotoxin injection here can further elevate the nasal tip.55
Filler can be used to adjust the nasal radix and dorsum. Since the skin on the radix is thicker than on the nasal dorsum, a high G’ filler with give enough lifting quality. A depot injection can be placed in this area, using small volumes.
Filler placed into the nasal dorsum can straighten the line between the radix and nasal tip, and can camouflage a dorsal